Nobel Laureate Jules Hoffmann's Team Collaborates with Infinitus on Advances in Polysaccharides and Immunity

May 16, 2024 04:02 AM AEST | By Cision

Google News:

Nobel Laureate Jules Hoffmann's Team Collaborates with Infinitus on Advances in Polysaccharides and Immunity — Image source: Kalkine Media

Recent News

Press Ganey Forsta Acquires InMoment, Accelerating AI Innovation in Cu...

Australia Non-Invasive Prenatal Testing Market Report 2025: NIPT Marke...

Global Plastics Treaty: The Journey of the Past Five Meetings

Rethinking Packaging With Purpose: A RENEWables Podcast Spotlight on E...

GUANGZHOU, China, May 16, 2024 /PRNewswire/ -- Recently, Professor Jean-Luc, Director of the Institute of Molecular Cell Biology at the French National Centre for Scientific Research (CNRS), Member of the Infinitus Global Scientific Advisory Board, and Principal Investigator of Hoffmann Infinitus Research Program, along with Associate Researcher Chen Di from the Sino-French Hoffmann Institute, and other distinguished colleagues, visited Infinitus for a technical exchange on complex polysaccharides and immunity. The event was attended by Ma Jun, Vice President and Chief Technology & Innovation Officer of Infinitus (China) Co., Ltd., Tang Jian, Director of Health Food R&D, Tang Qingtao, Director of Cosmetic R&D, and Li Wenzhi, Director of Frontier Technology Research.

Representatives from Prof. Hoffmann's team visit Infinitus Plaza in Guangzhou.

In 2017, Infinitus initiated a collaboration with the team led by Nobel Laureate in Physiology or Medicine, Prof. Jules Hoffmann, to create the Hoffmann Infinitus Program. The program, centered on immunology, aims to study the screening of functional factors, efficacy verification, and mechanisms of action for polysaccharide-based immunity products, specifically in the areas of immune regulation, antiviral activity, and enhancement of intestinal immunity. The research endeavor provides a scientific basis for the development and validation of Infinitus' products.

Prof. Imler and researchers from Infinitus discussed the progress of their ongoing collaborative projects, sharing insights on how to broaden and deepen future research endeavors related to complex polysaccharides and immunity.

During the seminar, Prof. Imler delivered an insightful presentation titled "Research on Immune Efficacy and Mechanism of Polysaccharide Combinations", highlighting the research outcomes of Infinitus in polysaccharide combinations in the realm of immune regulation and antiviral defense.

After the meeting, Mr. Ma Jun presented Prof. Imler with a certificate of appointment as Infinitus' Global Scientific Advisor. Prof. Imler expressed his enthusiasm for future collaborations and reaffirmed his commitment to integrating traditional Chinese medicine with modern technological advancements, aiming to assist Infinitus in capitalizing on emerging technological and product opportunities.

Looking ahead, Infinitus will continue to explore new frontiers in complex polysaccharides with a focus on the user. The company will enhance communication and collaboration with elite international expert teams, including Nobel Prize-winning researchers, to drive innovation in the core technology of complex polysaccharides. Additionally, Infinitus will apply our R&D outcomes to product development, ensuring that delivery of high-quality, reliable herbal health products. The goal is to foster a healthier and happier lifestyle for all.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.